Drug Type Small molecule drug |
Synonyms GAL-160 backup compounds, GAL-475 backup compounds |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization Enalare Therapeutics, Inc.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Altitude Sickness | Preclinical | US | Enalare Therapeutics, Inc.Startup | 31 Dec 2020 |
Pulmonary Disease, Chronic Obstructive | Preclinical | US | Enalare Therapeutics, Inc.Startup | 31 Dec 2020 |
Sleep Apnea Syndromes | Preclinical | US | Enalare Therapeutics, Inc.Startup | 31 Dec 2020 |